NH company shines light on UV therapy for autoimmune conditions
Started in 2021, Cytokind describes itself as 'the global leader in using UVB light to treat immune disorders and improve survival and the quality of life for patients'
Sections
Extras
Connect With Us

Elliot Hospital has begun offering two new technologies and procedures designed to help patients fight coronary artery disease, the most common type of heart disease.
The hospital offers Shockwave IVL (intravascular lithotripsy) and coronary orbital atherectomies to break up calcium in arteries and assist with stent implantation. Their use gives patients better outcomes, and they return to their activities sooner, it said.
The Shockwave IVL system modifies resistant calcium blockages in a patient’s coronary arteries. Shockwave uses sonic pressure waves to fracture challenging calcium, while minimizing trauma to a patient’s vessel wall.
The Elliot also offers coronary orbital atherectomies to patients. The diamondtipped device transmits pulsatile energy, with a dual mechanism of sanding superficial calcium and fracturing deep calcium. The oscillatory motion also permits blood flow through the artery during treatment, helping to minimize risk.
Started in 2021, Cytokind describes itself as 'the global leader in using UVB light to treat immune disorders and improve survival and the quality of life for patients'
Lebanon company’s technology helps surgeons pinpoint size, shape of tumors
Amid statewide shortage, schools and hospitals aim to increase workforce
Some state officials and lawmakers are concerned that New Hampshire’s incoming Medicaid premium system may conflict with provisions in Congress’ One Big Beautiful Bill Act.
American Medical Response (AMR) released its annual suspected opioid overdose statistical report earlier this month for New Hampshire’s two largest cities, Manchester and Nashua. Both communities experienced record low numbers.
Providing benefits aimed at meeting diverse needs may provide a more affordable approach to care
Cairn Surgical, Inc., a medical technology firm based in Lebanon, NH, announced earlier this month that patient enrollment has been completed in the U.S. pivotal trial of its Breast Cancer Locator (BCLTM) System.
Now that 2026 is underway, New Hampshire employers should turn their attention to the state’s new Parental Medical Leave law (PML). Effective January 1, 2026, most employers with 20 or more employees are required to provide unpaid leave to allow employees to attend childbirth-related medical appointments, postpartum care and pediatric visits during a child’s first year.
The federal government will give with one hand and take with another when it comes to New Hampshire’s rural health care system in 2026.